Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system
about
Molecular Mechanisms for Drug Hypersensitivity Induced by the Malaria Parasite's Chloroquine Resistance TransporterDynamic magnetic fields remote-control apoptosis via nanoparticle rotation.Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite's food vacuole and alter drug sensitivities.The subcellular distribution of small molecules: from pharmacokinetics to synthetic biologyRecent advances in delivery systems and therapeutics of cinnarizine: a poorly water soluble drug with absorption window in stomach.Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigensLysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance.Pigmented-MDCK (P-MDCK) cell line with tunable melanin expression: an in vitro model for the outer blood-retinal barrierDifferential cytotoxicity responses by dog and rat hepatocytes to phospholipogenic treatments.Targeted iron oxide nanoparticles for the enhancement of radiation therapy.Characterization of an influenza virus pseudotyped with Ebolavirus glycoprotein.Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation.Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles.
P2860
Q28552775-1A2A03C6-57A2-4CF6-B1DB-1684A9DDE144Q30577289-04754C8B-DFB1-4F3D-A47B-2F9088462DFBQ35947304-070FB19E-00C6-44C5-8181-2D9C22E806D9Q36106723-0A6AA413-3EA7-4132-A555-7BF671C96A19Q37909301-FD75ABA7-2CD7-4248-B1CB-585DBDB75E2DQ38283583-87B363DB-DA56-43AB-BE6A-7BFF9614D2C2Q38405361-B9EED39B-839F-445C-8243-16DE1941428EQ38924917-907E0415-1D06-4510-8186-1B993FDB2E81Q39273066-3021533A-C4FD-477A-95B7-91488CCEFD82Q39374963-771DE693-212D-4192-ABE7-AC14C4C77A3DQ41634307-EDF19C82-6421-4BFC-B45C-133AB47A4D62Q45323703-29BDA20B-D761-4E68-B19E-B1BB61E280C5Q50036781-854A3A04-5423-41EB-9DA1-79C4179BCAA2Q52348564-08EC69FC-A673-45B4-8905-B4D3F034AC6D
P2860
Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lipophilic cationic drugs incr ...... ranes in a cell culture system
@ast
Lipophilic cationic drugs incr ...... ranes in a cell culture system
@en
Lipophilic cationic drugs incr ...... ranes in a cell culture system
@nl
type
label
Lipophilic cationic drugs incr ...... ranes in a cell culture system
@ast
Lipophilic cationic drugs incr ...... ranes in a cell culture system
@en
Lipophilic cationic drugs incr ...... ranes in a cell culture system
@nl
prefLabel
Lipophilic cationic drugs incr ...... ranes in a cell culture system
@ast
Lipophilic cationic drugs incr ...... ranes in a cell culture system
@en
Lipophilic cationic drugs incr ...... ranes in a cell culture system
@nl
P2093
P50
P3181
P356
P1476
Lipophilic cationic drugs incr ...... ranes in a cell culture system
@en
P2093
Andrea Rotter
Andreas W Henkel
Oliver Welzel
Philipp Tripal
Stefan Bleich
Sven Städtler
P2860
P304
P3181
P356
10.1002/JCP.22112
P407
P577
2010-07-01T00:00:00Z